Suppr超能文献

家族性身材矮小

Familial Short Stature(Archived)

作者信息

Rajkumar Venkatraman, Waseem Muhammad

机构信息

Banting Clinic

Weill Cornell Medicine New York and New York Medical College, Valhalla NY

Abstract

Familial short stature (FSS) is a condition in which the final adult height achieved is less than the third percentile for the patient's age, gender, and population. Nevertheless, it is consistent with parental height in the absence of nutritional, hormonal, acquired, genetic, and iatrogenic causes. It is considered one of the most common causes of short stature, along with the constitutional delay in growth and puberty (CDGP), from which it can easily be distinguished. A child presenting with short stature (SS) two or more standard deviations (SD) below the mean for age, gender, and population where no other causes can be found deemed to have idiopathic short stature (ISS). Having adopted this definition, some authorities have included cases of FSS and CDGP as part of ISS. Hence, a category of familial ISS is distinguished from the non-familial ISS. On the other hand, others have listed it as a separate entity. Regardless of the classification which one follows, it is clear that FSS is a distinct entity whereby patients attain a final adult height consistent with their target height, unlike ISS. Thus, the final height attained is considerably less than the ultimate expected height in ISS. Although the consensus is that small cumulative effects of multiple genes are responsible for FSS, it is being questioned, especially when the SS condition is extreme. This may be especially true, as more and more monogenic gene defects are discovered in cases diagnosed either as FSS or ISS and other family members. This article addresses the features of FSS and covers distinctions among CDGP, ISS, and other causes of short stature. It also describes the latest advances in the study of various monogenic gene defects discovered in cases of SS, occurring in some families.

摘要

家族性矮小症(FSS)是一种成年终身高低于患者年龄、性别及人群第三百分位数的病症。然而,在不存在营养、激素、后天获得性、遗传及医源性病因的情况下,其与父母身高相符。它被认为是导致矮小症最常见的原因之一,与生长和青春期体质性延迟(CDGP)一同,且二者易于区分。一个年龄、性别及人群身高均值低于两个或更多标准差(SD)且无其他病因的矮小症(SS)患儿被认为患有特发性矮小症(ISS)。采用这一定义后,一些权威机构将FSS和CDGP病例纳入ISS范畴。因此,区分出了家族性ISS和非家族性ISS。另一方面,也有机构将其列为一个单独的实体。无论采用哪种分类方式,显然FSS是一个独特的实体,与ISS不同,FSS患者的成年终身高与其目标身高相符。因此,其成年终身高远低于ISS的最终预期身高。尽管普遍认为多个基因的微小累积效应导致了FSS,但这一观点正受到质疑,尤其是当矮小症情况极为严重时。随着越来越多在诊断为FSS或ISS的病例及其他家庭成员中发现的单基因缺陷被揭示,情况可能尤其如此。本文阐述了FSS的特征,并涵盖了CDGP、ISS及其他矮小症病因之间的区别。还描述了在一些家庭中出现的矮小症病例中发现的各种单基因缺陷研究的最新进展。

相似文献

2
Monogenic causes of familial short stature.家族性身材矮小的单基因病因。
Front Endocrinol (Lausanne). 2024 Dec 19;15:1506323. doi: 10.3389/fendo.2024.1506323. eCollection 2024.
9
Definition and prevalence of familial short stature.家族性身材矮小的定义和流行率。
Ital J Pediatr. 2021 Mar 9;47(1):56. doi: 10.1186/s13052-021-01018-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验